|
 |
On the cover: Medicine is the practice of the diagnosis, treatment, and prevention of disease. With the advances in medical science, human beings are getting both longer life spans and higher quality of life. From herbs to molecular signatures, humankind is experiencing a transition from traditional medicine to personalized medicine: the right treatment to the right patient at the right time. However, it is not so easy to achieve this goal because the etiology of most diseases and disorders is still unclear. From description to association, numerous researchers are working together to decipher the mechanisms behind disease. To address such challenges, more and more global collaborations are badly needed to include experts from all disciplines: not just doctors, scientists and administration staff, but also engineers, technicians and marketing managers. Not limited to a fish-eye view, we humans should widen our vision and get more deep insights beyond the human community. That is the right way to assure sustainable healthcare for humanity. |
|
|
Add comment (English only) |
|
|
|
|
|
Position: Home > issue > May 10, 2022 Volume 3, Issue 3 |
|
|
|
Another surprise in receptor binding of C. difficile toxins |
|
Clostridioides difficile (formerly named Clostridium difficile) is the dominant causative agent of a spectrum of illnesses, which frequently occur as the consequence of antibiotic treatment of patients. C. difficile infections (CDIs) cause mild to severe diarrhea (so-called antibiotic-associated diarrhea) but also pseudomembranous enterocolitis with complications like toxic megacolon, bowel perforation, and death. Three protein toxins are involved in the pathology of CDIs, toxin A (TcdA) and toxin B (TcdB), which are the prototypes of large clostridial glucosylating toxins, and C. difficile ADP-ribosyltransferase CDT.

|
|
|
|